Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebula: ORM-12741 for Agitation in Alzheimer's Disease
NCT02471196Phase 2Completed
- Sponsor
- Orion Corporation
- Start
- Aug 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ORM-12741 in Alzheimer's disease (AD), sponsored by Orion Corporation. Started Aug 2015; status: completed.
02
Drugs
ORM-12741
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02471196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02471196.